169 related articles for article (PubMed ID: 35121883)
21. FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling.
Shi Y; Ma Z; Cheng Q; Wu Y; Parris AB; Kong L; Yang X
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118877. PubMed ID: 33007330
[TBL] [Abstract][Full Text] [Related]
22. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
Gual P; Le Marchand-Brustel Y; Tanti JF
Biochimie; 2005 Jan; 87(1):99-109. PubMed ID: 15733744
[TBL] [Abstract][Full Text] [Related]
23. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
24. Differential actıvation and expression of insulin receptor substrate 1 (IRS1) in mononuclear cells of type 2 diabetes patients after insulin stimulation.
Gorgisen G; Balci MK; Celik FC; Gokkaya M; Ozdem S; Ozel D; Ozes ON
Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):25-30. PubMed ID: 26950447
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells.
Machado-Neto JA; Favaro P; Lazarini M; Costa FF; Olalla Saad ST; Traina F
Biochim Biophys Acta; 2011 Aug; 1813(8):1404-11. PubMed ID: 21569802
[TBL] [Abstract][Full Text] [Related]
26. EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer.
Tulchinsky E; Demidov O; Kriajevska M; Barlev NA; Imyanitov E
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):29-39. PubMed ID: 30419315
[TBL] [Abstract][Full Text] [Related]
27. IRS1Ser³⁰⁷ phosphorylation does not mediate mTORC1-induced insulin resistance.
Herrema H; Lee J; Zhou Y; Copps KD; White MF; Ozcan U
Biochem Biophys Res Commun; 2014 Jan; 443(2):689-93. PubMed ID: 24333417
[TBL] [Abstract][Full Text] [Related]
28. Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer.
Leong HS; Chong FT; Sew PH; Lau DP; Wong BH; Teh BT; Tan DS; Iyer NG
Stem Cells Transl Med; 2014 Sep; 3(9):1055-65. PubMed ID: 25024430
[TBL] [Abstract][Full Text] [Related]
29. Hypochlorous acid via peroxynitrite activates protein kinase Cθ and insulin resistance in adipocytes.
Zhou J; Wang Q; Ding Y; Zou MH
J Mol Endocrinol; 2015 Feb; 54(1):25-37. PubMed ID: 25381390
[TBL] [Abstract][Full Text] [Related]
30. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
Learn CA; Hartzell TL; Wikstrand CJ; Archer GE; Rich JN; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2004 May; 10(9):3216-24. PubMed ID: 15131063
[TBL] [Abstract][Full Text] [Related]
31. A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration.
Ruiz-Alcaraz AJ; Liu HK; Cuthbertson DJ; McManus EJ; Akhtar S; Lipina C; Morris AD; Petrie JR; Hundal HS; Sutherland C
Biochem J; 2005 Dec; 392(Pt 2):345-52. PubMed ID: 16128672
[TBL] [Abstract][Full Text] [Related]
32. IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors.
Porter HA; Perry A; Kingsley C; Tran NL; Keegan AD
Cancer Lett; 2013 Sep; 338(2):239-48. PubMed ID: 23562473
[TBL] [Abstract][Full Text] [Related]
33. Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: role of serine 24 phosphorylation.
Nawaratne R; Gray A; Jørgensen CH; Downes CP; Siddle K; Sethi JK
Mol Endocrinol; 2006 Aug; 20(8):1838-52. PubMed ID: 16574739
[TBL] [Abstract][Full Text] [Related]
34. Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells: IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE.
Hage Hassan R; Pacheco de Sousa AC; Mahfouz R; Hainault I; Blachnio-Zabielska A; Bourron O; Koskas F; Górski J; Ferré P; Foufelle F; Hajduch E
J Biol Chem; 2016 Feb; 291(6):3019-29. PubMed ID: 26698173
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
36. Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway.
Geetha T; Langlais P; Caruso M; Yi Z
J Endocrinol; 2012 Sep; 214(3):437-43. PubMed ID: 22728334
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of Irs1 at SER-522 inhibits insulin signaling.
Giraud J; Haas M; Feener EP; Copps KD; Dong X; Dunn SL; White MF
Mol Endocrinol; 2007 Sep; 21(9):2294-302. PubMed ID: 17579213
[TBL] [Abstract][Full Text] [Related]
38. The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor.
Peng J; Ramatchandirin B; Wang Y; Pearah A; Namachivayam K; Wolf RM; Steele K; MohanKumar K; Yu L; Guo S; White MF; Maheshwari A; He L
J Biol Chem; 2022 Mar; 298(3):101621. PubMed ID: 35074429
[TBL] [Abstract][Full Text] [Related]
39. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
40. Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.
Wang R; Yamada T; Kita K; Taniguchi H; Arai S; Fukuda K; Terashima M; Ishimura A; Nishiyama A; Tanimoto A; Takeuchi S; Ohtsubo K; Yamashita K; Yamano T; Yoshimura A; Takayama K; Kaira K; Taniguchi Y; Atagi S; Uehara H; Hanayama R; Matsumoto I; Han X; Matsumoto K; Wang W; Suzuki T; Yano S
Nat Commun; 2020 Sep; 11(1):4607. PubMed ID: 32929081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
